$\beta$-Cyclodextrin Reduces Obesity in C57BL/6J Mice Induced by High Fat Diet

  • Kim, Dae-Won (Central Research Center, Natural F&P Co., Ltd.) ;
  • Hwang, In-Koo (Department of Anatomy and Cell Biology, College of Veterinary Medicine and BK21 Program for Veterinary Science, Seoul National University) ;
  • Yoo, Ki-Yeon (Department of Anatomy and Neurobiology, College of Medicine, Hallym University) ;
  • Li, Hua (Department of Anatomy and Neurobiology, College of Medicine, Hallym University) ;
  • Pai, Tong-Kun (Department of Food and Nutrition, Anyang University) ;
  • Kim, Young-Sup (Medical Science Division, Korea Research Institute of Chemical Technology) ;
  • Kwon, Dae-Young (Korea Food Research Institute) ;
  • Kim, Dong-Woo (Central Research Center, Natural F&P Co., Ltd.) ;
  • Moon, Won-Kuk (Central Research Center, Natural F&P Co., Ltd.) ;
  • Won, Moo-Ho (Department of Anatomy and Neurobiology, College of Medicine, Hallym University)
  • Published : 2008.08.31

Abstract

Anti-obesity effects of $\beta$-cyclodextrin in obese C57BL/6J mice induced by a high fat diet (HD) were observed. The administration of $\beta$-cyclodextrin reduced the gain of body weight, abdominal fat, liver weight, the lipid deposits of hepatocytes and the size of adipocytes in the HD group. In serum analysis, the total and low-density lipoprotein-cholesterols were significantly decreased in the $\beta$-cyclodextrin-supplemented HD group than in the HD group. However, high-density lipoprotein-cholesterol was not changed in these groups. In hypothalamic homogenates, the decrease of neuropeptide Y and increase of $\alpha$-melanocyte stimulating hormone were detected in the $\beta$-cyclodextrin-supplemented HD group compared to that in the HD group. These effects of $\beta$-cyclodextrin were similar to those of Garcinia cambogia, which is widely used as a natural anti-obesity product. These results suggest that $\beta$-cyclodextrin has anti-obesity effects through the lowering of the abdominal fat pad and inhibits the central effects of hunger.

Keywords

References

  1. Pi-Synyer FX. Health implications of obesity. pp. 29-56. In: Obesity: Pathology and Therapy. Lockwood DH, Heffner TG (eds). Springer, Berlin, Germany (2000)
  2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. J. Am. Med. Assoc. 295: 1549-1555 (2006) https://doi.org/10.1001/jama.295.13.1549
  3. Gregoire FM, Zhang Q, Smith SJ, Tong C, Ross D, Lopez H, West DB. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICM-1-deficient mice. Am. J. Physiol.-Endoc. M. 282: E703-E713 (2002)
  4. West DB, Woguespack J, McColister S. Dietary obesity in the mouse: Interaction of strain with diet composition. Am. J. Physiol.-Reg. I. 268: R658-R665 (1995)
  5. Han D, Kwon EK, Kim DW, Kim YE, Lee CH, Kim IH. Biocellulose reduces body weight gain of rats fed high-fat diet. Food Sci. Biotechnol. 15: 70-76 (2006)
  6. Mun EG, Soh JR, Cha YS. L-Carnitine reduces obesity caused by high-fat diet in C57BL/6J mice. Food Sci. Biotechnol. 16: 228-233 (2007)
  7. Park E, Park NS, Park HR, Jin BR, Lee SM. Fruiting body extract of Paecilomyces tenuipes ameliorate lipid and antioxidant metabolism in rats fed a high fat-cholesterol diet. Food Sci. Biotechnol. 15: 710-714 (2006)
  8. Shin SJ, Hong ST. Acanthopanax and Playcodi independently prevents the onset of high fat diet induced hyperglyceridemia and obesity in C57BL/6 mice. Food Sci. Biotechnol. 14: 841-846 (2005)
  9. Irie T, Fukunaga K, Pitha J. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro. J. Pharm. Sci. 81: 521-523 (1992) https://doi.org/10.1002/jps.2600810609
  10. Bayne K. Revised guide for the care and use of laboratory animals available. American Physiological Society. Physiologist 39: 208-211 (1996)
  11. Hayamizu K, Hirakawa H, Oikawa D, Nakanishi T, Takagi T, Tachibana T, Furuse M. Effect of Garcinia cambogia extract on serum leptin and insulin in mice. Fitoterapia 74: 267-273 (2003) https://doi.org/10.1016/S0367-326X(03)00036-4
  12. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: A randomized controlled trial. J. Am. Med. Assoc. 280: 1596-1600 (1998) https://doi.org/10.1001/jama.280.18.1596
  13. Mori T, Kondo H, Hase T, Tokimitsu I, Murase T. Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J. Nutr. 137: 2629-2634 (2007) https://doi.org/10.1093/jn/137.12.2629
  14. Ferezou J, Riottot M, Sérougne C, Cohen-Solal C, Catala I, Alquier C, Parquet M, Juste C, Lafont H, Mathé D, Corring T, Lutton C. Hypocholesterolemic action of $\beta$-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol-enriched diet. J. Lipid Res. 38: 86-100 (1997)
  15. Abadie C, Hug M, Kübli C, Gains N. Effect of cyclodextrins and undigested starch on the loss of chenodeoxycholate in the faeces. Biochem. J. 299: 725-730 (1994) https://doi.org/10.1042/bj2990725
  16. Moundras C, Behr SR, Demigne C, Mazur A, Remesy C. Fermentable polysaccharides that enhance fecal bile acid excretion lower plasma cholesterol and apolipoprotein E-rich HDL in rats. J. Nutr. 124: 2179-2188 (1994) https://doi.org/10.1093/jn/124.11.2179
  17. Favier ML, Moundras C, Demigne C, Remesy C. Fermentable carbohydrates exert a more potent cholesterol-lowering effect than cholestyramine. Biochim. Biophys. Acta 1258: 115-121 (1995) https://doi.org/10.1016/0005-2760(95)00107-N
  18. Favier ML, Remesy C, Moundras C, Demigne C. Effect of cyclodextrin on plasma lipids and cholesterol metabolism in the rat. Metabolis. 44: 200-206 (1995) https://doi.org/10.1016/0026-0495(95)90265-1
  19. Flier JS. Obesity wars: Molecular progress confronts an expanding epidemic. Cell 116: 337-350 (2004) https://doi.org/10.1016/S0092-8674(03)01081-X
  20. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484 (2001) https://doi.org/10.1038/35078085
  21. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM, Grayson BE, Perello M, Nillni EA, Grove KL, Cowley MA. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5: 181-194 (2007) https://doi.org/10.1016/j.cmet.2007.02.004
  22. Patel HR, Qi Y, Hawkins EJ, Hileman SM, Elmquist JK, Imai Y, Ahima RS. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Diabetes 55: 3091-3098 (2006) https://doi.org/10.2337/db05-0624
  23. Park ES, Seong JK, Yi SJ, Kim JS, Lee HS, Lee IS, Yoon YS. Changes in orexin-A and neuropeptide y expression in the hypothalamus of obese and lean Zucker Diabetic Fatty rats. J. Vet. Med. Sci. 67: 639-646 (2005) https://doi.org/10.1292/jvms.67.639